IMPACT OF CFTR MODULATOR THERAPY (LEXACAFTOR/TEZACAFTOR/IVACAFTOR) ON PSEUDOMONAL COLONIZATION AND INFLAMMATION IN CYSTIC FIBROSIS

被引：0
|
作者：
Sheikh, Shahid I.
Britt, Rodney D.
Ryan-Wenger, Nancy A.
Khan, Aiman Q.
Gushue, Courtney A.
McCoy, Karen S.
Kopp, Benjamin
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
D O I：
10.1016/j.chest.2022.08.1278
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1519A / 1520A
页数：2
相关论文
共 50 条
  • [41] Elexacaftor-Tezacaftor-Ivacaftor Therapy for Chronic Sinus Disease in Cystic Fibrosis
    Sheikh, Shahid
    Ho, Mai-Lan
    Eisner, Mariah
    Gushue, Courtney
    Paul, Grace
    Holtzlander, Melissa
    Johnson, Terri
    McCoy, Karen S.
    Lind, Meredith
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2023, 149 (12) : 1075 - 1082
  • [42] Short-term effects of elexacaftor/tezacaftor/ivacaftor modulator therapy on glucose tolerance in young people with cystic fibrosis
    Korten, Insa
    Kieninger, Elisabeth
    Krueger, Linn
    Bullo, Marina
    Fluck, Christa E.
    Latzin, Philipp
    Casaulta, Carmen
    Boettcher, Claudia
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 90 - 91
  • [43] Impact of elexacaftor/tezacaftor/ivacaftor on bacterial cultures from people with cystic fibrosis
    Beck, Michael R.
    Hornick, Douglas B.
    Pena, Tahuanty A.
    Singh, Sachinkumar B.
    Wright, Brittany A.
    PEDIATRIC PULMONOLOGY, 2023, 58 (05) : 1569 - 1573
  • [44] Impact of elexacaftor/tezacaftor/ivacaftor on chronic rhinosinusitis in children with cystic fibrosis.
    Della Gatta, Beatrice
    Ronco, Lucia
    Peradotto, Federica
    Bignamini, Elisabetta
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [45] Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
    Williams, Cindy L.
    Billings, Joanna
    Mcgowan, Harriet
    Mcdevitt, Rebecca
    Esther Jr, Charles R.
    Mckinzie, Cameron J.
    Wilson, William S.
    Kam, Charissa W.
    PEDIATRIC PULMONOLOGY, 2025, 60 (03)
  • [46] Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis
    Piehler, Linus
    Thalemann, Ralf
    Lehmann, Christine
    Thee, Stephanie
    Roehmel, Jobst
    Syunyaeva, Zulfiya
    Stahl, Mirjam
    Mall, Marcus A.
    Graeber, Simon Y.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [47] Impact of elexacaftor/tezacaftor/ivacaftor on vitamin D absorption in cystic fibrosis patients
    Wright, Brittany A.
    Ketchen, Natalie K.
    Rasmussen, Leah N.
    Bartels, Alyssa R.
    Singh, Sachinkumar B.
    PEDIATRIC PULMONOLOGY, 2022, 57 (03) : 655 - 657
  • [48] Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome
    Marsh, Ryan
    Dos Santos, Claudio
    Hanson, Liam
    Ng, Christabella
    Major, Giles
    Smyth, Alan R.
    Rivett, Damian
    van der Gast, Christopher
    MICROBIOLOGY SPECTRUM, 2023, 11 (05):
  • [49] Tolerance of elexacaftor/tezacaftor/ivacaftor in Australians with cystic fibrosis
    Ruseckaite, Rasa
    Wark, Peter
    Pourghaderi, Ahmadreza
    Caruso, Marisa
    Ahern, Susannah
    RESPIROLOGY, 2024, 29 : 8 - 8
  • [50] Elucidating the Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Intolerance in People With Cystic Fibrosis
    Nielsen, Bibi Uhre
    Shaw, James A. M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025,
12345